These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37419417)

  • 21. Characterization of extended-spectrum-β-lactamase producing Klebsiella pneumoniae phage KP1801 and evaluation of therapeutic efficacy in vitro and in vivo.
    Wintachai P; Naknaen A; Thammaphet J; Pomwised R; Phaonakrop N; Roytrakul S; Smith DR
    Sci Rep; 2020 Jul; 10(1):11803. PubMed ID: 32678251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type.
    Li M; Xiao Y; Li P; Wang Z; Qi W; Qi Z; Chen L; Du H; Zhang W
    Arch Virol; 2020 Dec; 165(12):2799-2806. PubMed ID: 32989574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolating and sequencing vB_Kpn_3, a lytic bacteriophage against multidrug-resistant 
    Habibinava F; Soleimani M; Sabouri S; Zargar M; Zolfaghari MR
    Future Microbiol; 2022 Mar; 17():235-249. PubMed ID: 35152708
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
    Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and genome analysis of novel Klebsiella phage Henu1 with lytic activity against clinical strains of Klebsiella pneumoniae.
    Teng T; Li Q; Liu Z; Li X; Liu Z; Liu H; Liu F; Xie L; Wang H; Zhang L; Wu D; Chen M; Li Y; Ji A
    Arch Virol; 2019 Sep; 164(9):2389-2393. PubMed ID: 31214784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment.
    Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT
    J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.
    Cao F; Wang X; Wang L; Li Z; Che J; Wang L; Li X; Cao Z; Zhang J; Jin L; Xu Y
    Biomed Res Int; 2015; 2015():752930. PubMed ID: 25879036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Klebsiella virus UPM2146 lyses multiple drug-resistant Klebsiella pneumoniae in vitro and in vivo.
    Assafiri O; Song AA; Tan GH; Hanish I; Hashim AM; Yusoff K
    PLoS One; 2021; 16(1):e0245354. PubMed ID: 33418559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
    Fang Q; Zong Z
    mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying virulence determinants of multidrug-resistant Klebsiella pneumoniae in Galleria mellonella.
    Bruchmann S; Feltwell T; Parkhill J; Short FL
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33512418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A newly isolated bacteriophage vB8388 and its synergistic effect with aminoglycosides against multi-drug resistant Klebsiella oxytoca strain FK-8388.
    Zhao Y; Feng L; Zhou B; Zhang X; Yao Z; Wang L; Wang Z; Zhou T; Chen L
    Microb Pathog; 2023 Jan; 174():105906. PubMed ID: 36494020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key
    Blundell-Hunter G; Enright MC; Negus D; Dorman MJ; Beecham GE; Pickard DJ; Wintachai P; Voravuthikunchai SP; Thomson NR; Taylor PW
    Front Cell Infect Microbiol; 2021; 11():686090. PubMed ID: 34222050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model.
    Dhungana G; Regmi M; Paudel P; Parajuli A; Upadhyay E; Gyawali I; Upreti H; Nepal R; Pradhan P; Malla R
    J Nepal Health Res Counc; 2021 Apr; 19(1):76-82. PubMed ID: 33934137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and Genomic Analysis of a Novel Drexlervirial Bacteriophage IME268 with Lytic Activity Against
    Nazir A; Qi C; Shi N; Gao X; Feng Q; Qing H; Li F; Tong Y
    Infect Drug Resist; 2022; 15():1533-1546. PubMed ID: 35414748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant
    Bai J; Zhang F; Liang S; Chen Q; Wang W; Wang Y; Martín-Rodríguez AJ; Sjöling Å; Hu R; Zhou Y
    Front Cell Infect Microbiol; 2022; 12():897531. PubMed ID: 35865823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and biocontrol efficacy of lytic phage (KPP-1) that infects multidrug resistant Klebsiella variicola.
    Nikapitiya C; Chandrarathna HPSU; Dias MKHM; Lee J; De Zoysa M
    Braz J Microbiol; 2023 Sep; 54(3):2509-2520. PubMed ID: 37368195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and efficacy against carbapenem-resistant
    Wang Z; Yang X; Wang H; Wang S; Fang R; Li X; Xing J; Wu Q; Li Z; Song N
    Front Cell Infect Microbiol; 2024; 14():1382145. PubMed ID: 38736748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and Full Genome Sequence of Novel KPP-5 Lytic Phage against
    Sofy AR; El-Dougdoug NK; Refaey EE; Dawoud RA; Hmed AA
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33800632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.